MitraClip device for patients at moderate risk for surgery

Inclusion Criteria

• Must be 18 years old or older
• Must be at moderate surgical risk for mitral valve repair
• Must have severe mitral regurgitation
• Be willing to participate in the trial for 10 years

Exclusion Criteria

• Current participating in another clinical investigation
• Secondary mitral regurgitation
• Severe tricuspid regurgitation
• A heart attack in the last year
• Severe valve disease

Additional Info

• The MitraClip device is currently approved by the FDA for patients who are at high-risk for traditional surgery, but is not approved for patients considered moderate to low surgical risk.
• All treatments and physician visits during this study will take place at Anderson Medical Pavilion, Scripps La Jolla. Study participation will last up to 10 years